Sage Journals: Discover world-class research

Free access

Research article

First published 2016-3

Discovery and Characterization of a Biologically Active Non–ATP-Competitive p38 MAP Kinase Inhibitor

Brice A. P. Wilson, Muhammad S. Alam, Tad Guszczynski [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2010-4

A Non–ATP-Competitive Dual Inhibitor of JAK2 V617F and BCR-ABL T315I Kinases

Shashidhar S. Jatiani, Stephen C. Cosenza, M.V. Ramana Reddy [...]

Genes & Cancer

Open access

Research article

First published 2023-12

Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib

Lars van der Veen, Michael Schmitt, Marcel A. Deken [...]

International Journal of Toxicology

Free access

Research article

First published 2012-7

Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes

Connie S. Lebakken, Laurie J. Reichling, Jason M. Ellefson [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2013-7

The Use of TrkA-PathHunter Assay in High-Throughput Screening to Identify Compounds That Affect Nerve Growth Factor Signaling

Pontus Forsell, Helena Almqvist, Per Hillertz [...]

Journal of Biomolecular Screening

Retricted access

Research article

First published 2006-08

Enzyme Fragment Complementation Binding Assay for p38 α Mitogen-Activated Protein Kinase to Study the Binding Kinetics of Enzyme Inhibitors

Guido J.R. Zaman, Miranda M.C. van der Lee, Jacobus J. Kok [...]

ASSAY and Drug Development Technologies

Open access

Review article

First published 2023

Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review

Ehab Atallah, Lovneet Saini, Rodrigo Maegawa [...]

Therapeutic Advances in Hematology

Search results

Discovery and Characterization of a Biologically Active Non–ATP-Competitive p38 MAP Kinase Inhibitor

A Non–ATP-Competitive Dual Inhibitor of JAK2 V617F and BCR-ABL T315I Kinases

Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib

Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes

The Use of TrkA-PathHunter Assay in High-Throughput Screening to Identify Compounds That Affect Nerve Growth Factor Signaling

Enzyme Fragment Complementation Binding Assay for p38 α Mitogen-Activated Protein Kinase to Study the Binding Kinetics of Enzyme Inhibitors

Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review